Alpha Cognition Announces First Quarter 2023 Results and Provides Corporate Update

Author's Avatar
May 30, 2023

Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today reported financial results for the first quarter ended March 31, 2023 and provided a corporate update.